Policy Notices

• RESCINDED - Special Exception to the NIH/AHRQ/NIOSH Post-Submission Material Policy During the COVID-19 Pandemic
  (NOT-OD-20-123)
  National Institutes of Health
  

General Notices

• Pre-Application Webinar for NCI's Serological Sciences Network Funding Opportunities (RFA-CA-20-038, RFA-CA-20-039)
  (NOT-CA-20-074)
  National Cancer Institute
  National Institute of Allergy and Infectious Diseases
  

• Notice of Clarification to PAR-19-064, "Mechanism for Time-Sensitive Drug Abuse Research (R21 Clinical Trial Optional)"
  (NOT-DA-20-062)
  National Institute on Drug Abuse
  

• Notice of Pre-Application Webinar and Frequently Asked Questions (FAQs) for PAR-20-220 " Institutional Network Award for Promoting Kidney, Urologic, and Hematologic Research Training (U2C/TL1 - Clinical Trial Not Allowed) "
  (NOT-DK-20-027)
  National Institute of Diabetes and Digestive and Kidney Diseases
  

• Notice of Joint DMS/NIGMS Initiative to Support Research at the Interface of the Biological and Mathematical Sciences
  (NOT-GM-20-036)
  National Institute of General Medical Sciences
  

• Notice of Availability of National Childrens Study (NCS) Vanguard Biological and Environmental Sample Materials
  (NOT-HD-20-018)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  

• Notice of Participation of National Institute of Nursing Research (NINR) in PA-20-135 "Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Trial Optional")
  (NOT-NR-20-005)
  National Institute of Nursing Research
  

• Guide Notice of Information Highlighting Harmonization and Data Sharing Expectations for Supplement and Revision Projects Addressing Social, Behavioral, Economic and Health Impacts of the COVID-19 Public Health Emergency
  (NOT-OD-20-118)
  National Institutes of Health
  

• Guidance Regarding Change in Status, Including Absence of PD/PI and Other Key Personnel Named in the Notice of Award
  (NOT-OD-20-124)
  National Institutes of Health
  

• Notice of Pre-Application Webinars for the High-Risk, High-Reward Research Program's Pioneer, New Innovator, Transformative Research, and Early Independence Awards
  (NOT-RM-20-021)
  Office of Strategic Coordination (Common Fund)
  

• Request for Information: Soliciting Input on the NIGMS 2021-2025 Strategic Plan Framework
  (NOT-GM-20-034)
  National Institute of General Medical Sciences
  

Notice of Changes to Funding Opportunities

• Notice of NLM's Participation in PA-20-135 "Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Trial Optional)"
  (NOT-LM-20-012)
  National Library of Medicine
  

• Notice of NIMH Participation in PA-20-135, "Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Trial Optional)"
  (NOT-MH-20-064)
  National Institute of Mental Health
  

• Notice of Extension of the Response Date for NOT-NS-20-026 "Request for Information: Soliciting Input on Areas of Health Disparities and Inequities in Neurological Disease and/or Care in the United States Across the Lifespan"
  (NOT-NS-20-075)
  National Institute of Neurological Disorders and Stroke
  

• Notice of Change in Application Due Date for NOT-OD-20-107 "Notice of Special Interest (NOSI): Administrative Supplements to Existing NIH ECHO Cooperative Agreements (Admin Supp - Clinical Trial Not Allowed) for COVID-19 related Research"
  (NOT-OD-20-117)
  National Institutes of Health
  

Notices of Intent to Publish

• Notice of Intent to Publish a Funding Opportunity Announcement for INIA Research Project (U01 Clinical Trial Optional)
  (NOT-AA-20-016)
  National Institute on Alcohol Abuse and Alcoholism
  

Notices of Special Interest

• Notice of Special Interest (NOSI): NIAID Priorities for Biomedical Knowledgebases & Repositories
  (NOT-AI-20-044)
  National Institute of Allergy and Infectious Diseases
  

• Notice of Special Interest (NOSI): Role of Astrocytes and Astrocytic Networks in Drug Abuse
  (NOT-DA-20-060)
  National Institute on Drug Abuse
  

• Notice of Special Interest (NOSI): Bold New Bioengineering Research for Heart, Lung, Blood and Sleep Disorders and Diseases (Reissue)
  (NOT-HL-20-796)
  National Heart, Lung, and Blood Institute
  

• Notice of Special Interest (NOSI): Emergency Competitive Revisions for Social, Ethical, and Behavioral Implications (SEBI) Research on COVID-19 Testing among Underserved and/or Vulnerable Populations
  (NOT-OD-20-119)
  National Institutes of Health
  John E. Fogarty International Center
  National Center for Advancing Translational Sciences
  National Center for Complementary and Integrative Health
  National Cancer Institute
  National Eye Institute
  National Human Genome Research Institute
  National Heart, Lung, and Blood Institute
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Allergy and Infectious Diseases
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Institute of Biomedical Imaging and Bioengineering
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Institute of Dental and Craniofacial Research
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Institute of Environmental Health Sciences
  National Institute of General Medical Sciences
  National Institute of Mental Health
  National Institute on Minority Health and Health Disparities
  National Institute of Neurological Disorders and Stroke
  National Institute of Nursing Research
  National Library of Medicine
  Office of Behavioral and Social Sciences Research
  Office of Disease Prevention
  Office of Research on Women's Health
  

• Notice of Special Interest (NOSI): Emergency Competitive Revisions for Community-Engaged Research on COVID-19 Testing among Underserved and/or Vulnerable Populations
  (NOT-OD-20-120)
  National Institutes of Health
  John E. Fogarty International Center
  National Center for Advancing Translational Sciences
  National Center for Complementary and Integrative Health
  National Cancer Institute
  National Eye Institute
  National Human Genome Research Institute
  National Heart, Lung, and Blood Institute
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Allergy and Infectious Diseases
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Institute of Biomedical Imaging and Bioengineering
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Institute of Dental and Craniofacial Research
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Institute of Environmental Health Sciences
  National Institute of General Medical Sciences
  National Institute of Mental Health
  National Institute on Minority Health and Health Disparities
  National Institute of Neurological Disorders and Stroke
  National Institute of Nursing Research
  National Library of Medicine
  Office of Behavioral and Social Sciences Research
  Office of Disease Prevention
  Office of Research on Women's Health
  

• Notice of Special Interest (NOSI): Limited Competition for Emergency Competitive Revisions for Community-Engaged Research on COVID-19 Testing among Underserved and/or Vulnerable Populations
  (NOT-OD-20-121)
  National Institutes of Health
  National Center for Advancing Translational Sciences
  National Center for Complementary and Integrative Health
  National Cancer Institute
  National Eye Institute
  National Human Genome Research Institute
  National Heart, Lung, and Blood Institute
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Allergy and Infectious Diseases
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Drug Abuse
  National Institute of Dental and Craniofacial Research
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Institute of Environmental Health Sciences
  National Institute of General Medical Sciences
  National Institute of Mental Health
  National Institute on Minority Health and Health Disparities
  National Institute of Neurological Disorders and Stroke
  National Institute of Nursing Research
  National Library of Medicine
  Office of Behavioral and Social Sciences Research
  Office of Disease Prevention
  Office of Research on Women's Health
  

Funding Opportunities

• Administrative Supplement for Research on Dietary Supplements (Admin Supp-Clinical Trial Not Allowed)
  (PA-20-227)
  Office of Dietary Supplements
  John E. Fogarty International Center
  National Center for Complementary and Integrative Health
  National Cancer Institute
  National Eye Institute
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Allergy and Infectious Diseases
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Institute of Biomedical Imaging and Bioengineering
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Deafness and Other Communication Disorders
  National Institute of Dental and Craniofacial Research
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Institute of Environmental Health Sciences
  National Institute on Minority Health and Health Disparities
  Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
  Application Receipt Date(s): October 15, 2020; January 15, 2021; April 15, 2021; October 15, 2021; January 15, 2022; April 15, 2022; October 15, 2022; January 15, 2023; April 15, 2023, by 5:00 PM local time of applicant organization. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  
  

• Pilot Projects Increasing the Impact of the NIH Centers for Advancing Research on Botanicals and Other Natural Products (PI2 CARBON) (R03 Clinical Trials Not Allowed)
  (PAR-20-228)
  Office of Dietary Supplements
  National Center for Complementary and Integrative Health
  Application Receipt Date(s): Oct 1,2020; June 1, 2021; February 1, 2022;September 30, 2022. Resubmissions: Oct 15, 2020; June 15, 2021; February 15, 2022; October 14, 2022.
  
  

• Global Infectious Disease Research Training Program (D43 Clinical Trial Optional)
  (PAR-20-229)
  John E. Fogarty International Center
  National Institute of Allergy and Infectious Diseases
  Application Receipt Date(s): August 14, 2020, August 3, 2021, August 3, 2022 All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  
  

• Center for Inherited Disease Research (CIDR) High Throughput Sequencing and Genotyping Resource Access (X01)
  (PAR-20-230)
  National Human Genome Research Institute
  Application Receipt Date(s): Applications are accepted by continuous receipt. All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s) Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  
  

• Claude D. Pepper Older Americans Independence Centers (P30 Clinical Trial Optional)
  (RFA-AG-21-024)
  National Institute on Aging
  Application Receipt Date(s): October 29, 2020 All applications are due by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  
  

• Improving Smoking Cessation Interventions among People Living with HIV (R01 Clinical Trial Optional)
  (RFA-CA-20-035)
  National Cancer Institute
  National Institute on Drug Abuse
  National Institute on Minority Health and Health Disparities
  Application Receipt Date(s): Only accepting applications for the AIDS Application Due Date(s) listed below.
  
  

• Improving Smoking Cessation Interventions among People Living with HIV (R21 Clinical Trial Optional)
  (RFA-CA-20-036)
  National Cancer Institute
  National Institute on Drug Abuse
  Application Receipt Date(s): Only accepting applications for the AIDS Application Due Date(s) listed below.
  
  

• Collaborative Centers in Children's Environmental Health Research and Translation Centers (P2C Clinical Trial Optional)
  (RFA-ES-20-001)
  National Institute of Environmental Health Sciences
  Application Receipt Date(s): November 23, 2020 All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date
  
  

• Emergency Awards: RADx-UP Coordination and Data Collection Center (CDCC) (U24 Clinical Trial Optional)
  (RFA-OD-20-013)
  National Institutes of Health
  John E. Fogarty International Center
  National Center for Advancing Translational Sciences
  National Center for Complementary and Integrative Health
  National Cancer Institute
  National Eye Institute
  National Human Genome Research Institute
  National Heart, Lung, and Blood Institute
  National Institute on Aging
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Institute of Biomedical Imaging and Bioengineering
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Institute of Dental and Craniofacial Research
  National Institute of Environmental Health Sciences
  National Institute of General Medical Sciences
  National Institute of Mental Health
  National Institute on Minority Health and Health Disparities
  National Institute of Nursing Research
  National Library of Medicine
  Office of Behavioral and Social Sciences Research
  Office of Disease Prevention
  Office of Research on Women's Health
  Application Receipt Date(s): August 7, 2020 No late applications will be accepted for this Funding Opportunity Announcement..